Related Experiment Videos

[Hereditary angioedema. Description of a pediatric case]

R Danieli1, M Pesce, L Vizzoni

  • 1Divisione Pediatria Medica, Spedali Riuniti di Livorno.

Minerva Pediatrica
|November 1, 1991
PubMed

Insights

Hereditary angioedema, a rare genetic disorder, results from C1-esterase inhibitor deficiency. Early diagnosis in children is crucial for managing potentially fatal swelling episodes.

Area of Science:

  • Immunology
  • Genetics
  • Vascular Biology

Background:

  • Hereditary angioedema (HAE) is a rare genetic disorder caused by a deficiency or dysfunction of the serum inhibitor of C1-esterase (C1-INH).
  • HAE is characterized by recurrent episodes of severe swelling (angioedema) affecting the skin, gastrointestinal tract, and upper airways.
  • Laryngeal edema, a severe manifestation of HAE, can be life-threatening, with up to 50% of untreated cases being fatal.

Observation:

  • This report details a case of hereditary angioedema diagnosed in a pediatric patient.
  • The diagnosis in childhood highlights the importance of considering HAE in the differential diagnosis of recurrent swelling in young individuals.
  • The case underscores the challenges and significance of early identification in pediatric angioedema.

Findings:

  • The study focuses on a pediatric case of hereditary angioedema, emphasizing the clinical presentation and diagnostic process.
  • The underlying cause, C1-esterase inhibitor deficiency or anomaly, is central to the disease pathophysiology.
  • Recurrent episodes of subcutaneous and mucosal edema are the hallmark clinical features.

Implications:

  • Early diagnosis of hereditary angioedema in pediatric patients is critical for timely intervention and management.
  • Prompt treatment can prevent potentially fatal complications, such as laryngeal edema.
  • Increased awareness and diagnostic vigilance for HAE in children are essential for improving patient outcomes.

Related Concept Videos